A second Trump administration could mean higher prices, less nutrition, and an increased risk of pathogens in the food supply ...

RFK Jr., a lawyer-politician, could replace lawyer-politician Xavier Becerra as Secretary of Health and Human Services. Or ...

Fortunately, the FDA has approved antipsychotic treatments that help manage these destructive symptoms, and more are in ...

The Food and Drug Administration could now revoke over-the-counter designations for phenylephrine, an active ingredient in Benadryl and Sudafed. Pfizer’s COVID-19 pill: Here’s the latest on ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

From family planning to hospital bills, the new Trump administration has the potential to affect a wide range of policies in ...

Former President Donald Trump has boasted in recent months about "Right to Try," a law he signed in 2018. It’s aimed at boosting terminally ill patients’ access to potentially life-saving medications ...

The longtime anti-vaccine activist may be tapped as a White House czar, overseeing agencies responsible for vaccine approvals ...

today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL), dated October 22, 2024, for the ketamine Abbreviated New Drug Application, which was ...

to the U.S. Food and Drug Administration (FDA) for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran is ...